Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Agios Pharmaceuticals Inc (AGIO)

  • Business News
  • June 11, 2025, 10:20 UTC
  • 4

Avanzanite annonce un partenariat paneuropéen avec Agios pour le lancement de PYRUKYND® dans les maladies rares du sang

Market reaction Comment Full text

Cabaletta Bio Inc (CABA)

  • Business News
  • June 11, 2025, 10:15 UTC
  • 4

Cabaletta Bio Announces Proposed Public Offering of Securities

Market reaction Comment Full text

Cabaletta Bio Inc (CABA)

  • Business News
  • June 11, 2025, 10:00 UTC
  • 5

Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress

Market reaction Comment Full text

Insulet Corporation (PODD)

  • Business News
  • June 11, 2025, 09:00 UTC
  • 6

Insulet - Insulet and Marvel Collaborate to Launch Comic Book Hero with Type 1 Diabetes Featuring Omnipod® 5, Empowering the Diabetes Community Through Representation

Market reaction Comment Full text

Agios Pharmaceuticals Inc (AGIO)

  • Business News
  • June 11, 2025, 08:36 UTC
  • 9

Avanzanite gibt europaweite Partnerschaft mit Agios zur Einführung von PYRUKYND® bei seltenen Blutgerinnungsstörungen bekannt

Market reaction Comment Full text

MaxCyte Inc (MXCT)

  • Business News
  • June 11, 2025, 06:05 UTC
  • 9

MaxCyte and Ori Biotech Announce Collaboration

Market reaction Comment Full text

MaxCyte Inc (MXCT)

  • Business News
  • June 11, 2025, 06:01 UTC
  • 7

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 11, 2025, 05:17 UTC
  • 8

Avengers: Doomsday – Everything We Know So Far About Marvel’s Mega Crossover

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 11, 2025, 04:56 UTC
  • 7

Now You See Me 4 Officially in the Works as Franchise Expands Beyond 2025

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 11, 2025, 04:42 UTC
  • 8

James Gunn’s Next Superman Project Won’t Be a Traditional Sequel By Design

Market reaction Comment Full text
  • Previous
  • 260
  • 261
  • 262
  • 263
  • 264
  • Next

Search

News categories

  • Technical Exchange News(9543)
  • Event(407)
  • SEC News(156487)
  • FDA Approval(8929)
  • Company Report(721)
  • Business News(106214)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin